Pavella Therapeutics Inc. PVLA
$110.03
▲ +2.28% 24H
About
Pavella Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for rare genetic disorders. The primary function of the company is to research and advance treatments that address unmet medical needs in the realm of genetic diseases, leveraging advanced biotechnological innovations. The c…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees29
TickerPVLA
Statistics
Market Cap$1.57B
Revenue (TTM)—
Net Income-$41.7M
Net Margin—
EPS$-3.71
P/E13.69
P/S—
P/B6.55
EV/EBITDA-34.70
ROE-34.2%
Dividend Yield—
Price$110.03
Data: Twelve Data · Revenue = mcap / P/S